US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Oakridge International Limited (OAK) 銘柄情報

Oakridge International Limited (OAK)

0.082

0.002

(2.50%)

終了 6月24日 3:00PM

Oakridge International Limited (OAK) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.082

( 2.50% )

買値

0.08

売値

0.083

出来高

25,572

0.079 日の範囲 0.082

0.063 52 週間の範囲 0.145

時価総額

前日終値

0.08

始値

0.079

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 44,308

発行済株式数

26,997,908

配当利回り

PER

12.65

1 株当たり利益 (EPS)

0.01

歳入

3.12M

純利益

170.41k

Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sector... Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities. The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It is also involved in the development of Internet of Things technology. The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited is based in Adelaide, Australia. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

www.oakridgeint.com

本社

Adelaide, Australia

設立

-

Oakridge International Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker OAK. The last closing price for Oakridge was AUD0.08. Over the last year, Oakridge shares have traded in a share price range of AUD 0.063 to AUD 0.145.

Oakridge currently has 26,997,908 shares in issue. The market capitalisation of Oakridge is AUD2.21 million. Oakridge has a price to earnings ratio (PE ratio) of 12.65.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.002	2.5	0.08	0.082	0.079	11402	0.08	DE
4	-0.002	-2.38095238095	0.084	0.088	0.079	21266	0.08345155	DE
12	0.018	28.125	0.064	0.145	0.064	41703	0.08776155	DE
26	0.007	9.33333333333	0.075	0.145	0.063	30155	0.08436437	DE
52	0.019	30.1587301587	0.063	0.145	0.063	25542	0.08177147	DE
156	0.007	9.33333333333	0.075	0.175	0.047	23040	0.0790448	DE
260	0.081	8100	0.001	0.34	0.001	370707	0.01168612	DE

OAK - Frequently Asked Questions (FAQ)

What is the current Oakridge International Limited share price?

The current share price of Oakridge International Limited is AUD 0.082

How many Oakridge International Limited shares are in issue?

Oakridge International Limited has 26,997,908 shares in issue

What is the market cap of Oakridge International Limited?

The market capitalisation of Oakridge International Limited is AUD 2.21M

What is the 1 year trading range for Oakridge International Limited share price?

Oakridge International Limited has traded in the range of AUD 0.063 to AUD 0.145 during the past year

What is the PE ratio of Oakridge International Limited?

The price to earnings ratio of Oakridge International Limited is 12.65

What is the cash to sales ratio of Oakridge International Limited?

The cash to sales ratio of Oakridge International Limited is 0.69

What is the registered address of Oakridge International Limited?

The registered address for Oakridge International Limited is 89 Pirie Street, Adelaide, South Australia, 5000

What is the Oakridge International Limited website address?

The website address for Oakridge International Limited is www.oakridgeint.com

Which industry sector does Oakridge International Limited operate in?

Oakridge International Limited operates in the Healthcare Providers & Services sector

ToyotaMR2s

ToyotaMR2s 5分前

ToyotaMR2s

ToyotaMR2s 9分前

eagle8

eagle8 10分前

Hope4Patients reposted
alphavestcapital.com
@alphavestcap
by The Danish Dude:
$nwbo
@alphavestcap

Northwest Biotherapeutics will present major findings at the British Neuro-Oncology Society conference, with Dr. Marnix Bosch delivering resul

satter

satter 17分前

As someone already pointed out, payment could have been made by credit card, debit card also.

No payment could come from a bank under a garnishment order.

US Market News

US Market News 21分前

Forrester: Nine In 10 US Marketing Agencies Use AI To Cut Costs At The Expense Of CreativityJune 24, 2026 3:00 AM
Business Wire New research calls on agencies and CMOs to shift their focus from AI-driven cost savings to preserving creativity and differentiation

US Market News

US Market News 21分前

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEOJune 24, 2026 3:05 AM
Business Wire Board of Directors appoints Julie Kim as Representative Director, President & CEO following share

US Market News

US Market News 36分前

Signatera™ Receives Regulatory Approval in Japan for Colorectal CancerJune 24, 2026 3:00 AM
Business Wire First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant setting Commer

timberwolf7

timberwolf7 41分前

If you want the cheapest shares you can get? One would think
that would entail being patient for it to confirm a BOTTOM is in before
buying shares (aka, the 'cheapest' you would be able to get em).

I have no idea where this is going to stop sliding at. Just playing t

MightyX

MightyX 41分前

Likely strategic move to avoid OTC

MightyX

MightyX 42分前

Notice how they’re going from NASDAQ to NYSE

dinogreeves

dinogreeves 43分前

I am betting on 3 team parlay, Jason Kalisman, Atlanta Braves and New York Yankees, although I don't know much about baseball, but I do have my favorite, Anaheim Angels. Welp, off to bed, going to have great night sleep after listening to "I found my love in Portofino" by Andrea Bocelli.

PC retired

PC retired 43分前

Thank you, Mr Bystander. I would reckon this is only the start of the infighting and many similar cases are in the pipeline.

watcher777

watcher777 47分前

Has anyone ever Googled the address and looked on maps where the LLCs that bought professor Li's shares is located? It's a shack in Florida. I'm so glad I woke up. 😆
2804 Dawley Ave, Orlando, FL 32806

Plato_

Plato_ 47分前

Have one on the House! 🍻HEAR, HEAR. VeeMo $ t

US Market News

US Market News 51分前

MSCI Acquires First Street to Enhance Physical Climate Risk Capabilities for Financial Decision MakingJune 24, 2026 2:33 AM
Business Wire MSCI Inc. (NYSE: MSCI) is enhancing its global physical climate risk capabilities with the acquisition of First Street, a leading provider o

watcher777

watcher777 51分前

He has/had every right to be. However, I hope he can let this go and move on. These people are not worth the sweat off his sack.

vinmantoo

vinmantoo 51分前

I would have loved a deal already, especially one that would have avoided a raise at 10 dollars. That said right now the type of deal you might pursue very well may depend on a few factors that are around the corner. The two lawsuits, and the first clinical readout in immunology. That might give you

Mdk1

The importance of critical minerals ! Mrima Hill rare earth and niobium deposit ...
>>> "Every major power understands that whoever controls the supply chains controls the future."
https://www.armstrongeconomics.com/international-news/africa/us-strikes-deal-for-kenyas-rare-earth-miner

watcher777

watcher777 54分前

I'm leaning towards not. I was invested in this thing for a long time. I've been to the shareholder meetings, spoke with the executives, shook professor Li's hand, had breakfast with Tony and I'm convinced there is a very slight chance this company will ever be profitable. The technology is amazing!

Genz2

Is Elon Musk like Henry Ford? Does he want to be like Henry Ford??

sentiment_stocks

sentiment_stocks 58分前

If MHRA did find the application was bogus… as you suggest… then they are corrupt, or just idiots.

vinmantoo

vinmantoo 1時間前

Echoes of EDP-235.

As Dew said, Zeli isn't close to what happened with EDP-235 as Zeli not only completed phase 2 with stellar results for high risk but has been given the go ahead given for phase 3.EDP-235 only had early stage trial data.. Add in that Paxlovid was already on the mark

InvestorinAZ

InvestorinAZ 1時間前

Clicked on your link and it says
"No results found for the past 5 years. Consider expanding the filed date range!"
Send a new link please. Not sure what you're looking at.

In all my conversations with the folks at VP, they've all said that they're not allowed to sell s

Excite Technology Services

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。